SCHEMBL6018094

SCHEMBL6018094

Nc1cc(F)c(Br)cc1C(=O)O.Nc1cc(F)c(Br)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
KEAP1 Q14145 2/20 0.50
GLA P06280 1/20 0.50
IDO1 P14902 1/20 0.46
KMT2A Q03164 3/20 0.44
GFER P55789 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TDP1 Q9NUW8 3/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 2/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
PKM P14618 1/20 0.42
APEX1 P27695 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
MCL1 Q07820 1/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL994342 1.00 KDM4E (0.50) KDM4EKEAP1GLAIDO1KMT2A
Hydrochloric Acid SCHEMBL21494383 0.98 KDM4E (0.48) KDM4EKEAP1GLAIDO1KMT2A
SCHEMBL2726898 0.92 KDM4E (0.50) KDM4EKEAP1GLAIDO1KMT2A
Hydrochloric Acid SCHEMBL18954184 0.90 KDM4E (0.48) KDM4EKEAP1GLAIDO1KMT2A
SCHEMBL20327005 0.84 DGAT1 (0.48) KDM4EKEAP1GLAALDH1A1CA1
SCHEMBL17049160 0.84 KDM4E (0.46) KDM4EKEAP1GLAIDO1KMT2A
SCHEMBL24697741 0.83 KEAP1 (0.45) KDM4EKEAP1GLAKMT2AMEN1
SCHEMBL1047232 0.83 KDM4E (0.57) KDM4EKEAP1GLAIDO1KMT2A
SCHEMBL222733 0.83 KEAP1 (0.57) KDM4EKEAP1GLAIDO1KMT2A
SCHEMBL21513677 0.82 DGAT1 (0.35) KDM4EKEAP1GLADGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1882586-A 1H-imidazo[4,5-C]quinoline derivatives in the treatment of protein kinase dependent diseases NOVARTIS AG (CH) 2006-12-20 CN disclosed
EP-1689747-A1 1H-IMIDAZO [4,5-C] QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES Novartis AG (CH) 2006-08-16 EP disclosed
WO-2005054238-A1 1H-IMIDAZO[4,5-C]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES NOVARTIS AG (CH) 2005-06-16 WO disclosed